Tomasz Drewa

Dr. Tomasz Drewa


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2021 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
MOMagdalena Ostrowska
Magdalena Ostrowska
MGMagdalena Mariusz Grześk-Kaczyńska
Magdalena Mariusz Grześk-Kaczyńska
SKSzymon Mariusz Kaczyński
Szymon Mariusz Kaczyński
DSDominika Skwara
Dominika Skwara
KKKacper Kulik
Kacper Kulik
TDTomasz Drewa
Tomasz Drewa
Zinner syndrome (ZS) is a rare disorder that affects only men. It is characterized by a triad of abnormalities, including unilateral renal agenesis, ipsilateral seminal vesicle cysts, and atresia of the ejaculatory tract. Unfortunately, there is no consensus on the best treatment modality. We describe a case of a young male patient with recurrent epididymitis, dysuria, and frequent urination. In the diagnostic evaluation, we found an extended right seminal vesicle in the ultrasound with hyperechoic fluid inside and an absence of the right kidney. We performed magnetic resonance imaging, computed tomography, and semen analysis confirming Zinner syndrome and deteriorated semen parameters. Urethroscopic evaluation and ultrasound-guided puncture of the seminal vesicle were performed. An abscess was excluded. The cytologic evaluation showed hemosiderophages. Tamsulosin was introduced. We found no signs of relapse in a six-month observation, and the patient had no further symptoms. Therefore, minimally invasive treatment is a feasible option in young patients found with early-stage Zinner syndrome.

7 April 2022 in Life
Verified
Journal Article
Open access
PDF file
MMMalgorzata Maj
Malgorzata Maj
ŁKŁukasz Kaźmierski
Łukasz Kaźmierski
KBKarolina Balik
Karolina Balik
KKKarolina Kowalska
Karolina Kowalska
LGLidia Gackowska
Lidia Gackowska
TDTomasz Drewa
Tomasz Drewa
Stem cell-based therapies are considered one of the most promising disciplines in biomedicine. Bladder cancer patients could benefit from therapies directed to promote healing after invasive surgeries or to lessen urinary incontinence, a common side effect of both cancer itself and the treatment. However, the local delivery of cells producing large amounts of paracrine factors may alter interactions within the microenvironment. For this reason, reconstructive cellular therapies for patients with a history of cancer carry a potential risk of tumor reactivation. We used an indirect co-culture model to characterize the interplay between adipose-derived stem cells and bladder cancer cells. Incubation with ASCs increased MCP-1 secretion by bladder cancer cells (from 2.1-fold to 8.1-fold, depending on the cell line). Cancer cell-derived factors altered ASC morphology. Cells with atypical shapes and significantly enlarged volumes appeared within the monolayer. Incubation in a conditioned medium (CM) containing soluble mediators secreted by 5637 and HB-CLS-1 bladder cancer cell lines decreased ASC numbers by 47.5% and 45.7%. A significant increase in adhesion to ECM components, accompanied by reduced motility and sheet migration, was also observed after incubation in CM from 5637 and HB-CLS-1 cells. No differences were observed when ASCs were co-cultured with HT-1376 cells. Our previous and present results indicate that soluble mediators secreted by ASCs and bladder cancer cells induce opposite effects influencing cells that represent the non-muscle-invasive urinary bladder.

18 October 2024 in Cancers
Verified
Journal Article
Open access
PDF file
OPOleksii Pisotskyi
Oleksii Pisotskyi
PPPiotr Petrasz
Piotr Petrasz
PZPiotr Zorga
Piotr Zorga
MGMarcin Gałęski
Marcin Gałęski
PSPawel Szponar
Pawel Szponar
JAJan Adamowicz
Jan Adamowicz
Objective: This study aimed to evaluate the correlation between 68Ga-PSMA uptake in PSMA PET/CT in primary prostate cancer (PC) and its histopathological grading (Gleason score and ISUP grade). Additionally, we compared preoperative biopsy histopathological findings with definitive pathology results in radical prostatectomy (RP) specimens. Methods: We retrospectively analyzed 86 patients who underwent 68Ga-PSMA PET/CT for primary PC staging, of which 40 patients later underwent radical prostatectomy. PET/CT results, including SUVmax values, were correlated with GS and PSA concentrations. Histopathology reports were analyzed and compared between biopsy and final pathology results following RP. Results: A significant positive correlation was observed between SUVmax and ISUP grades (Pearson’s ρ = 0.34, p < 0.001), with higher SUVmax values associated with more advanced grades. A cut-off SUVmax value of 5.64 was determined to predict upstaging in patients, yielding a sensitivity of 76% and a specificity of 60% (AUC = 0.82, 95% CI: 0.70–0.94). Additionally, 57.5% of patients experienced a grade shift following RP, with a 35% upgrade and 22.5% downgrade in ISUP grades. Conclusion: 68Ga-PSMA PET/CT demonstrated high sensitivity in detecting high-risk prostate cancer, particularly in patients with GS > 7 or PSA levels ≥ 10 ng/mL. The findings suggest that this imaging modality may be less effective for the staging of patients with lower GS or PSA values, that is, low-risk PCa. Further prospective studies are necessary to validate these results.

27 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
OPOleksii Pisotskyi
Oleksii Pisotskyi
PPPiotr Petrasz
Piotr Petrasz
PZPiotr Zorga
Piotr Zorga
MGMarcin Gałęski
Marcin Gałęski
PSPawel Szponar
Pawel Szponar
JAJan Adamowicz
Jan Adamowicz
Objective: The study aims to evaluate the correlation between 68Ga-PSMA uptake in PSMA PET/CT in primary prostate cancer (PC) and its histopathological grading (Gleason Score and ISUP grade). Additionally, we compared preoperative biopsy histopathological findings with definitive pathology results in radical prostatectomy (RP) specimens. Methods: We retrospectively analyzed 86 patients who underwent 68Ga-PSMA PET/CT for primary PC staging, of which 40 patients later underwent radical prostatectomy. PET/CT results, including SUVmax values, were correlated with GS and PSA concentrations. Histopathology reports were analyzed and compared between biopsy and final pathology results following RP. Results: A significant positive correlation was observed between SUVmax and ISUP grades (Pearson's ρ = 0.34, p < 0.001), with higher SUVmax values associated with more advanced grades. A cut-off SUVmax value of 5.64 was determined to predict upstaging in patients, yielding a sensitivity of 76% and a specificity of 60% (AUC = 0.82, 95% CI: 0.70–0.94). Additionally, 57.5% of patients experienced a grade shift following RP, with a 35% upgrade and 22.5% downgrade in ISUP grades. Conclusion: 68Ga-PSMA PET/CT demonstrated high sensitivity in detecting high-risk prostate cancer, particularly in patients with GS > 7 or PSA levels ≥ 10 ng/ml. The findings suggest that this imaging modality may be less effective for staging of patients with lower GS or PSA values, that is low-risk PCa. Further prospective studies are necessary to validate these results.

12 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
OPOleksii Pisotskyi
Oleksii Pisotskyi
PPPiotr Petrasz
Piotr Petrasz
PZPiotr Zorga
Piotr Zorga
MGMarcin Gałęski
Marcin Gałęski
PSPawel Szponar
Pawel Szponar
JAJan Adamowicz
Jan Adamowicz
Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (Ga-68 PSMA-PET/CT) is a diagnostic tool used in urology to detect oligometastatic disease in patients with prostate cancer (PC). Although increasingly popular and extensively studied, it is not considered a standard diagnostic tool for primary PC staging, because it lacks validation when compared to mpMRI.Numerous studies have suggested its promising role in PC diagnostics. Our objective was to comprehensively review and summarize the existing literature on the potential and feasibility of utilizing Ga-68 PSMA-PET/CT as the sole method for primary PC staging and to compare it with currently employed diagnostic tools (mainly mpMRI). The main goal of the study was to consolidate the data on the sensitivity and specificity of PSMA-PET for PCa staging when compared with other diagnostic tools. The use of PSMA-PET/CT as the only diagnostic tool of primary PC in the future might potentially reduce diagnostic time and costs. In addition, we examined the limitations of its use. Ga-68 PSMA-PET/CT demonstrates encouraging outcomes during the initial assessment of PC, potentially leading to a transformative leap in PC diagnosis and treatment, due to the utilization of Ga-68 PSMA, with high affinity to prostate cells.

1 January 2024 in AIP Conference Proceedings
Verified
Conference Paper
Closed access
PDF file
MPMarta Pokrywczyńska
Marta Pokrywczyńska
PSPaweł Skrzydlewski
Paweł Skrzydlewski
ZFZuzanna Fekner
Zuzanna Fekner
MBMonika Buhl
Monika Buhl
TDTomasz Drewa
Tomasz Drewa
AJArkadiusz Jundziłł
Arkadiusz Jundziłł
The aim of this study was to elaborate a decellularization protocol of adipose tissue for soft tissue engineering. For this purpose, three selected decellulariz The aim of this study was to elaborate a decellularization protocol of adipose tissue for soft tissue engineering. For this purpose, three selected decellulariz